Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 178,872 | 176,954 | 169,878 | 122,975 | 131,329 |
| Marketable Securities | 197,676 | 246,459 | 359,775 | 464,109 | 510,094 |
| Receivables | 6,362 | 8,587 | 7,689 | 7,720 | 6,259 |
| TOTAL | $398,769 | $447,396 | $554,064 | $606,944 | $659,668 |
| Non-Current Assets | |||||
| PPE Net | 51,523 | 50,816 | 49,588 | 45,222 | 41,324 |
| Investments And Advances | 88,169 | 95,631 | 49,205 | 42,431 | 50,530 |
| Intangibles | 93,462 | 95,458 | 97,799 | 96,577 | 100,926 |
| Other Non-Current Assets | 90,000 | 83,097 | 84,707 | 85,921 | 86,102 |
| TOTAL | $323,154 | $325,002 | $281,299 | $270,151 | $278,882 |
| Total Assets | $721,923 | $772,398 | $835,363 | $877,095 | $938,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,759 | 7,982 | 10,132 | 11,638 | 12,553 |
| Accrued Expenses | 20,840 | 18,646 | 17,406 | 13,077 | 20,738 |
| TOTAL | $127,887 | $131,898 | $136,943 | $132,839 | $143,547 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 85,711 | 90,454 | 93,957 | 94,364 | 91,644 |
| Other Non-Current Liabilities | 45,272 | 43,752 | 44,758 | 45,697 | 45,478 |
| TOTAL | $218,693 | $234,484 | $252,963 | $274,839 | $297,637 |
| Total Liabilities | $346,580 | $366,382 | $389,906 | $407,678 | $441,184 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 145,968 | 145,675 | 145,337 | 143,882 | 143,251 |
| Common Shares | 1,459 | 1,455 | 1,451 | 1,437 | 1,421 |
| Retained earnings | -956,267 | -918,771 | -871,083 | -823,914 | -777,981 |
| Other shareholders' equity | -3,987 | -623 | 1,987 | -224 | 4,551 |
| TOTAL | $375,343 | $406,016 | $445,457 | $469,417 | $497,366 |
| Total Liabilities And Equity | $721,923 | $772,398 | $835,363 | $877,095 | $938,550 |